Y-mAbs Therapeutics, Inc.

NasdaqGS:YMAB Stock Report

Mkt Cap: US$193.9m

Y-mAbs Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:YMAB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Nov 22BuyUS$5,884Vignesh RajahIndividual1,195US$4.92
09 Feb 22SellUS$2,021,188Thomas GadIndividual281,170US$7.59
04 Feb 22SellUS$1,055,558Thomas GadIndividual136,164US$7.90

Insider Trading Volume

Insider Buying: YMAB insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of YMAB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,259,6212.9%
Private Companies4,178,4659.6%
VC/PE Firms5,285,23212.1%
General Public10,363,95823.7%
Institutions22,580,85451.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.57%
Wg Biotech Aps
4,178,465$18.6m0%no data
7.08%
HBM Partners Ltd.
3,090,954$13.7m0%1.41%
6.64%
BlackRock, Inc.
2,897,394$12.9m-2.65%no data
5.8%
Polar Capital Holdings plc
2,531,546$11.2m-14.26%0.05%
5.02%
Sofinnova Investment, Inc.
2,194,278$9.7m0%0.67%
4.92%
AllianceBernstein L.P.
2,150,064$9.5m-23.64%no data
4.46%
Wellington Management Group LLP
1,948,469$8.7m4.18%no data
4.4%
The Vanguard Group, Inc.
1,920,421$8.5m-0.49%no data
4.39%
State Street Global Advisors, Inc.
1,919,139$8.5m10.1%no data
3.16%
FMR LLC
1,378,466$6.1m-30.06%no data
1.94%
Medical Strategy GmbH, Asset Management Arm
848,867$3.8m2.2%0.24%
1.55%
Thomas Gad
675,032$3.0m0%no data
1.45%
Geode Capital Management, LLC
632,895$2.8m1.07%no data
1.06%
Walleye Capital LLC
463,951$2.1m11.49%0.03%
1.02%
Mpm Oncology Impact Management, L.P.
443,702$2.0m0%0.48%
0.92%
Artal Group S.A.
400,000$1.8m0%0.09%
0.75%
Northern Trust Global Investments
329,023$1.5m-1.22%no data
0.68%
Driehaus Capital Management LLC
297,252$1.3m0%0.01%
0.57%
Charles Schwab Investment Management, Inc.
248,415$1.1m0%no data
0.54%
Morgan Stanley, Investment Banking and Brokerage Investments
234,903$1.0m-33.58%no data
0.49%
Perceptive Advisors LLC
212,018$941.4k0%0.03%
0.44%
Memorial Sloan Kettering Cancer Center, Endowment Arm
191,176$848.8k0%2.58%
0.41%
Bo Kruse
181,077$804.0k0%no data
0.4%
Candriam Luxembourg S.A.
172,584$766.3k0%no data
0.39%
Lombard Odier Asset Management (Switzerland) SA
168,795$749.4k-6.71%0.01%